In addition, some studies have shown that GLP1R agonists can improve mortality, increase left ventricular ejection fraction, and attenuate the level of brain natriuretic peptide in the patients with type 2 diabetes and HF. The gene discussed is NPPB; the disease is hydrops fetalis.